SPRB
Spruce Biosciences Inc. (SPRB)
NASDAQ · Healthcare
Spruce Biosciences Inc. annual/quarterly long term debt history from 2022 to 2024. Long term debt refers to financial obligations that are due more than one year in the future.
- Spruce Biosciences Inc. long term debt for the quarter ending December 31, 2024 were 1.8M, a 50.44% decrease year-over-year.
- Spruce Biosciences Inc. long term debt for 2024 were 1.8M, a 50.44% decrease from 2023.
- Spruce Biosciences Inc. long term debt for 2023 were 3.7M, a 34.19% decrease from 2022.
- Spruce Biosciences Inc. long term debt for 2022 were 5.6M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Spruce Biosciences Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2024 | $2 |
| 2023 | $4 |
| 2022 | $6 |
| Spruce Biosciences Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2024-12-31 | $2 |
| 2023-12-31 | $4 |
| 2022-12-31 | $6 |
Spruce Biosciences Inc. Long Term Debt — FAQ
Spruce Biosciences Inc. (SPRB) long term debt over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SPRB's long term debt history?
The chart and table above show Spruce Biosciences Inc.'s long term debt by year and by quarter, including the growth rate.